Modifications

=== [[GcMAF]] ===

=== [[GcMAF]] ===

[[image:Dario_SiniscalcoI_GcMAF.jpg|Dario Sinicalco avec les autres conférenciers à 1re conférence Gc-MAF à Frankfurt (Francfort) du 19 au 21 avril 2013. Assis devant et de gauche à droite: Dr Kenny de Meirleir, Dr Emar Vogelaar, David Noakes, Dr Siniscalco et Dr Jeffrey Bradstreet. Source <ref>http://www.gcmaf.asia/conferences/previous-conferences/ La photo est présentée avec la remarque suivante"''Immuno Biotech Ltd was proud to sponsor the world’s first ever GcMAF conference''". Le directeur d'Immuno Biotech Ldt, qui aura par la suite quelques ennuis avec les autorités sanitaires, est David Noakes, celui qui trône au centre de la photo</ref>|400px|thumb]]

[[image:Dario_SiniscalcoI_GcMAF.jpg|Jeff Bradstreet avec les autres conférenciers à 1re conférence Gc-MAF à Frankfurt (Francfort) du 19 au 21 avril 2013. Assis devant et de gauche à droite: Dr Kenny de Meirleir, Dr Emar Vogelaar, David Noakes, Dr Siniscalco et Dr Jeffrey Bradstreet. Source <ref>http://www.gcmaf.asia/conferences/previous-conferences/ La photo est présentée avec la remarque suivante"''Immuno Biotech Ltd was proud to sponsor the world’s first ever GcMAF conference''". Le directeur d'Immuno Biotech Ldt, qui aura par la suite quelques ennuis avec les autorités sanitaires, est David Noakes, celui qui trône au centre de la photo</ref>|400px|thumb]]

D'autres traitements que Bradstreet utilise fréquemment sur ​​les enfants autistes comprennent la GcMAF (Gc protein-derived Macrophage Activating Factor), avec lequel il prétend avoir traité 600 enfants<ref>http://www.prweb.com/releases/2012/9/prweb9857174.htm Publié le 8 septembre 2012 :<br>Dr Bradstreet has treated 600 children with GcMAF in the USA and will publicise some of his results at the Treating Autism Conference on September 9th and in a paper being published afterwards.<br>Dr Bradstreet tested hundreds of children for Nagalase and found over 80% had high levels. High Nagalase levels indicates the presence of viruses and a severely weakened immune system. 46 research papers by 107 eminent scientists prove [[GcMAF]] restores the immune system, and reduces nagalase down to healthy levels.<br>Dr [[Nicola Antonucci]] in Italy treated 94 children with autism, 83 had significant improvements, and he believes [[GcMAF]] to be the most effective treatment of autism. It is essential to ensure the GcMAF has been tested with live cell (eg macrophage cell) assays, or it may not be active. [...] Report on Autism treated with [[GcMAF]] in Italy by Dr. [[Nicola Antonucci|Antonucci]] and Dr. [[Dario Siniscalco|Siniscalco]] [...]</ref>.

D'autres traitements que Bradstreet utilise fréquemment sur ​​les enfants autistes comprennent la GcMAF (Gc protein-derived Macrophage Activating Factor), avec lequel il prétend avoir traité 600 enfants<ref>http://www.prweb.com/releases/2012/9/prweb9857174.htm Publié le 8 septembre 2012 :<br>Dr Bradstreet has treated 600 children with GcMAF in the USA and will publicise some of his results at the Treating Autism Conference on September 9th and in a paper being published afterwards.<br>Dr Bradstreet tested hundreds of children for Nagalase and found over 80% had high levels. High Nagalase levels indicates the presence of viruses and a severely weakened immune system. 46 research papers by 107 eminent scientists prove [[GcMAF]] restores the immune system, and reduces nagalase down to healthy levels.<br>Dr [[Nicola Antonucci]] in Italy treated 94 children with autism, 83 had significant improvements, and he believes [[GcMAF]] to be the most effective treatment of autism. It is essential to ensure the GcMAF has been tested with live cell (eg macrophage cell) assays, or it may not be active. [...] Report on Autism treated with [[GcMAF]] in Italy by Dr. [[Nicola Antonucci|Antonucci]] and Dr. [[Dario Siniscalco|Siniscalco]] [...]</ref>.